Published in Can J Ophthalmol on July 01, 1978
Protection of macaques against vaginal transmission of a pathogenic HIV-1/SIV chimeric virus by passive infusion of neutralizing antibodies. Nat Med (2000) 11.90
Control of viremia and prevention of clinical AIDS in rhesus monkeys by cytokine-augmented DNA vaccination. Science (2000) 9.92
Protection of Macaques against pathogenic simian/human immunodeficiency virus 89.6PD by passive transfer of neutralizing antibodies. J Virol (1999) 9.11
ALVAC-SIV-gag-pol-env-based vaccination and macaque major histocompatibility complex class I (A*01) delay simian immunodeficiency virus SIVmac-induced immunodeficiency. J Virol (2002) 4.11
Ia antigen expression on human epidermal Langerhans cells. Nature (1977) 4.05
Tumour-specific antibodies in human malignant melanoma and their relationship to the extent of the disease. Br Med J (1969) 3.37
Possible immunological factors in human malignant melanoma in Uganda. Lancet (1967) 3.16
Autoimmunization with irradiated tumour cells in human malignant melanoma. Br Med J (1970) 2.91
The classification of malignant melanoma and its histologic reporting. Cancer (1973) 2.67
Experience with a three-hour electron microscopy biopsy service. J Clin Pathol (1974) 2.33
Immunological studies in nephrotic syndrome associated with extrarenal malignant disease. Lancet (1971) 2.22
Brief report: idiotypic IgA nephropathy in patients with human immunodeficiency virus infection. N Engl J Med (1992) 1.90
Neuropeptides and neurotrophins in neonatal blood of children with autism or mental retardation. Ann Neurol (2001) 1.87
Air guns: the main cause of enucleation secondary to trauma in children and young adults in the greater Ottawa area in 1974-93. Can J Ophthalmol (1995) 1.84
Immunologic function and survival in hemodialysis patients. Kidney Int (1998) 1.82
Neonatal cytokines and coagulation factors in children with cerebral palsy. Ann Neurol (1998) 1.80
Complications of cancer immunotherapy with levamisole. Lancet (1977) 1.76
The specificity of surface membrane immunofluorescence in human malignant melanoma. Int J Cancer (1972) 1.75
Cryotherapy for conjunctival primary acquired melanosis and malignant melanoma. Experience with 62 cases. Ophthalmology (1988) 1.69
The spectrum of postmortem ocular findings in victims of shaken baby syndrome. Can J Ophthalmol (2001) 1.62
Congenital hereditary (juvenile X-linked) retinoschisis. Histopathologic and ultrastructural findings in three eyes. Arch Ophthalmol (1986) 1.61
Abscessed hydroxyapatite orbital implants. A report of two cases. Ophthalmology (1996) 1.58
Malignant melanoma in Uganda. (The relationship between pigmentation and malignant melanoma on the soles of the feet). Br J Cancer (1967) 1.56
Circulating immune complexes in schistosomiasis due to Schistosoma mansoni. Br Med J (1975) 1.51
Augmentation of immune responses to HIV-1 and simian immunodeficiency virus DNA vaccines by IL-2/Ig plasmid administration in rhesus monkeys. Proc Natl Acad Sci U S A (2000) 1.50
Presence of anti-pituitary hormone antibodies in patients with empty sella syndrome and pituitary tumours. Clin Endocrinol (Oxf) (1993) 1.49
Multiple viral determinants contribute to pathogenicity of the acutely lethal simian immunodeficiency virus SIVsmmPBj variant. J Virol (1993) 1.49
Control of SIV rebound through structured treatment interruptions during early infection. Science (2000) 1.48
Nephrotic syndrome in malignant disease of non-renal origin. Lancet (1971) 1.42
Protection of macaques with a simian immunodeficiency virus envelope peptide vaccine based on conserved human immunodeficiency virus type 1 sequences. Proc Natl Acad Sci U S A (1991) 1.37
The pathogenesis of reflux nephropathy (chronic atrophic pyelonephritis). Br J Radiol (1975) 1.30
Transgenic mice carrying the mouse mammary tumor virus ras fusion gene: distinct effects in various tissues. Mol Cell Biol (1989) 1.24
Cystoid macular edema with equatorial choroidal melanoma. Arch Ophthalmol (1978) 1.23
Mucoepidermoid carcinoma of the conjunctiva with intraocular invasion. Ophthalmology (1981) 1.20
Magnesium-deficiency elevates circulating levels of inflammatory cytokines and endothelin. Mol Cell Biochem (1992) 1.18
Neutralizing antibodies in sera from macaques immunized with attenuated simian immunodeficiency virus. J Virol (1998) 1.18
The incidence and distribution of pigmented naevi in Ugandan Africans. Br J Dermatol (1968) 1.17
Epstein-Barr virus shedding by astronauts during space flight. Brain Behav Immun (2005) 1.16
Protection against feline leukemia by vaccination with a subunit vaccine. Infect Immun (1981) 1.16
Malignant melanoma of the nasal cavity in Ugandan Africans. Relationship of ectopic pigmentation. Cancer (1967) 1.16
Aspects of behavior and natural history of malignant melanoma in Uganda. Cancer (1968) 1.15
Epithelioid hemangioma of the orbit. Ophthalmology (2000) 1.14
Mucoepidermoid carcinoma of the conjunctiva: a series of three cases. Ophthalmology (2000) 1.14
Evidence for recombination of live, attenuated immunodeficiency virus vaccine with challenge virus to a more virulent strain. J Virol (2000) 1.13
Herpes simplex type 2 encephalitis concurrent with known cerebral metastases. Acta Neuropathol (1979) 1.13
Vaccine-elicited immune responses prevent clinical AIDS in SHIV(89.6P)-infected rhesus monkeys. Immunol Lett (2001) 1.13
Protection of rhesus macaques against disease progression from pathogenic SHIV-89.6PD by vaccination with phage-displayed HIV-1 epitopes. Nat Med (2001) 1.11
The prevalence of macular drusen in postmortem eyes. Am J Ophthalmol (1986) 1.11
Target role of Langerhans cells in mycosis fungoides: transmission and immuno-electron microscopic studies. J Cutan Pathol (1979) 1.10
Atheromatous plaques of the retinal blood vessels. Histologic confirmation of ophthalmoscopically visible lesions. Arch Ophthalmol (1973) 1.07
Pseudophakic bullous keratopathy. A clinical-pathologic analysis. Can J Ophthalmol (1979) 1.07
A histopathological, ultrastructural and immunohistochemical study of congenital hereditary retinoschisis. Can J Ophthalmol (1996) 1.04
Trisomy 22 and facioauriculovertebral (Goldenhar) sequence. Am J Med Genet (1993) 1.04
Dyadic relationship conflict, gender, and mortality in urban hemodialysis patients. J Am Soc Nephrol (2000) 1.03
The use of Vicryl mesh (polyglactin 910) for implantation of hydroxyapatite orbital implants. Ophthal Plast Reconstr Surg (1995) 1.03
A light and electron microscopic study of anterior subcapsular cataracts. Am J Ophthalmol (1974) 1.03
Fetal antigens in nonneoplastic conditions. Cancer Res (1976) 1.02
Combined surgery and cryotherapy for diffuse malignant melanoma of the conjunctiva. Arch Ophthalmol (1980) 1.02
Mediators of fetal inflammation in extremely low gestational age newborns. Cytokine (2001) 1.02
Pathobiology of magnesium deficiency: a cytokine/neurogenic inflammation hypothesis. Am J Physiol (1992) 1.02
Peters' anomaly: a clinicopathologic study. J Pediatr Ophthalmol Strabismus (1993) 1.01
Immunological and virological changes associated with decline in CD4/CD8 ratios in lymphoid organs of SIV-infected macaques. AIDS Res Hum Retroviruses (1994) 1.01
Keratoconus with spontaneous perforation of the cornea. Can J Ophthalmol (1987) 1.00
Infectivity of titered doses of simian immunodeficiency virus clone E11S inoculated intravenously into rhesus macaques (Macaca mulatta). J Med Primatol (1994) 0.99
Immunoregulation by neuropeptides in magnesium deficiency: ex vivo effect of enhanced substance P production on circulating T lymphocytes from magnesium-deficient mice. Magnes Res (1996) 0.99
Blockade of cardiac inflammation in Mg2+ deficiency by substance P receptor inhibition. Circ Res (1994) 0.98
Microvascular assessment of burn depth conversion during varying resuscitation conditions. J Burn Care Rehabil (2001) 0.97
HIV-associated immune-mediated renal disease. Kidney Int (1993) 0.97
Immunologic studies in patients with malignant melanoma in Uganda. Br J Cancer (1969) 0.96
A histochemical, fluorescent, and electron microscopic examination. Am J Ophthalmol (1973) 0.96
Virus-induced cytokines regulate circulating lymphocyte levels during primary SIV infections. Int Immunol (1997) 0.95
The significance of humoral antibodies in the localization of human malignant melanoma. Br J Surg (1973) 0.95
Presentation of SIVgag to monkey T cells using dendritic cells transfected with a recombinant adenovirus. Eur J Immunol (2000) 0.95
Stereoselective reduction of pyruvate by sodium borohydride catalyzed by pyruvate kinase. Biochim Biophys Acta (1973) 0.95
Carcinoma-associated hemolytic-uremic syndrome: a complication of mitomycin C chemotherapy. J Clin Oncol (1985) 0.95
Adaptation of HIV-1 to pigtailed macaques. J Med Primatol (1994) 0.95
Pyogenic granuloma following oculoplastic procedures: an imbalance in angiogenesis regulation? Can J Ophthalmol (2001) 0.95
Congenital heart disease at necropsy in Uganda. A 16-years survey at Mulago Hospital, Kampala. Br Heart J (1969) 0.94
Neurogenic peptides and the cardiomyopathy of magnesium-deficiency: effects of substance P-receptor inhibition. Mol Cell Biochem (1994) 0.94
Immunological associations of the halo naevus with cutaneous malignant melanoma. Br J Dermatol (1973) 0.94
Post-traumatic corneal mucormycosis caused by Absidia corymbifera. Ophthalmology (1997) 0.93
Endogeneous Nocardia subretinal abscess. Arch Ophthalmol (1996) 0.93
Unilateral megalencephaly, cerebral cortical dysplasia, neuronal hypertrophy, and heterotopia: cytomorphometric, fluorometric cytochemical, and biochemical analyses. Acta Neuropathol (1979) 0.93
A system of immunofluorescence in the study of tumour cells. Rev Eur Etud Clin Biol (1970) 0.93
Persistent cutaneous insulin allergy resulting from high-molecular-weight insulin aggregates. Diabetes (1990) 0.92
Pseudomonas aeruginosa scleritis. Am J Ophthalmol (1981) 0.92
Langerhans cells: involvement in the pathogenesis of mycosis fungoides. Br J Dermatol (1976) 0.92
Presence and possible role of anti-IgG antibodies in human malignancy. Lancet (1974) 0.92
Uveal melanoma presenting as post-traumatic choroidal hemorrhage and panophthalmitis. Can J Ophthalmol (1977) 0.92
Ocular neurofibromatosis. Ophthalmology (1983) 0.92